Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 459 views
- JPMorgan Bringing Back Employees to Work From Office 454 views
- Ferari Poaches New CEO From Tech Industry 420 views
- China Unveils Maglev Train With a Top Speed of 600 kph 370 views
- Apple Employee Claims to Have Been Dismissed After Leading Movement Against Harassment 335 views